These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21705274)

  • 1. Another dopamine agonist for treatment of restless legs syndrome.
    Earley CJ
    Lancet Neurol; 2011 Aug; 10(8):675-7. PubMed ID: 21705274
    [No Abstract]   [Full Text] [Related]  

  • 2. Rotigotine and restless legs syndrome: new indication. The worst dopamine agonist. Just as unsatisfactory; defective design.
    Prescrire Int; 2009 Oct; 18(103):197. PubMed ID: 19882782
    [No Abstract]   [Full Text] [Related]  

  • 3. Rotigotine for restless legs syndrome.
    Davies S
    Drugs Today (Barc); 2009 Sep; 45(9):663-8. PubMed ID: 19956807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacology sheet. Transdermal Rotigotine (Neupro)].
    J Pharm Belg; 2010 Jun; (2):49-50. PubMed ID: 20623986
    [No Abstract]   [Full Text] [Related]  

  • 5. Rotigotine transdermal delivery for the treatment of restless legs syndrome.
    Sixel-Döring F; Trenkwalder C
    Expert Opin Pharmacother; 2010 Mar; 11(4):649-56. PubMed ID: 20163275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From bench to bedside: An overview of rotigotine for the treatment of restless legs syndrome.
    Bogan RK
    Clin Ther; 2014 Mar; 36(3):436-55. PubMed ID: 24636821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotigotine: a novel dopamine agonist for the transdermal treatment of Parkinson's disease.
    Zareba G
    Drugs Today (Barc); 2006 Jan; 42(1):21-8. PubMed ID: 16511608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal rotigotine in restless legs syndrome: impulse control disorders.
    Prescrire Int; 2014 Oct; 23(153):239. PubMed ID: 25964969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotigotine: transdermal dopamine agonist treatment of Parkinson's disease and restless legs syndrome.
    Splinter MY
    Ann Pharmacother; 2007 Feb; 41(2):285-95. PubMed ID: 17213296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology and efficacy of rotigotine (Neupro® patch) in the treatment of restless leg syndrome.
    Ferini-Strambi L; Marelli S; Galbiati A
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):967-75. PubMed ID: 27224246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating restless legs syndrome with rotigotine.
    Reading P
    Br J Hosp Med (Lond); 2010 Apr; 71(4):216-9. PubMed ID: 20393432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotigotine transdermal patch in the treatment of Parkinson's disease and restless legs syndrome.
    Kenney C; Jankovic J
    Expert Opin Pharmacother; 2007 Jun; 8(9):1329-35. PubMed ID: 17563266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transdermal Rotigotine in the treatment of restless legs patients who develop augmentation of symptoms].
    Miranda C M
    Rev Med Chil; 2013 Mar; 141(3):407-8. PubMed ID: 23900336
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of restless legs syndrome with rotigotine.
    García-Borreguero D; Oertel W; Trenkwalder C;
    Lancet Neurol; 2011 Oct; 10(10):872-3. PubMed ID: 21939896
    [No Abstract]   [Full Text] [Related]  

  • 15. Rotigotine: the first new chemical entity for transdermal drug delivery.
    McAfee DA; Hadgraft J; Lane ME
    Eur J Pharm Biopharm; 2014 Nov; 88(3):586-93. PubMed ID: 25173087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotigotine Transdermal Patch: A Review in Restless Legs Syndrome.
    Garnock-Jones KP
    Drugs; 2016 Jul; 76(10):1031-40. PubMed ID: 27324269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One year open-label safety and efficacy trial with rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome.
    Oertel WH; Benes H; Garcia-Borreguero D; Geisler P; Högl B; Trenkwalder C; Tacken I; Schollmayer E; Kohnen R; Stiasny-Kolster K;
    Sleep Med; 2008 Dec; 9(8):865-73. PubMed ID: 18753003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rotigotine. One patch, two targets!].
    Sabourin G
    Perspect Infirm; 2013; 10(4):60. PubMed ID: 24046901
    [No Abstract]   [Full Text] [Related]  

  • 19. Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study.
    Stiasny-Kolster K; Kohnen R; Schollmayer E; Möller JC; Oertel WH;
    Mov Disord; 2004 Dec; 19(12):1432-8. PubMed ID: 15390055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal rotigotine (Neupro) for Parkinson's disease.
    Med Lett Drugs Ther; 2007 Aug; 49(1268):69-70. PubMed ID: 17712291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.